Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Rapid Screen for Tyrosine Kinase Inhibitor Resistance Mutations and Substrate Specificity.

Taft JM, Georgeon S, Allen C, Reckel S, DeSautelle J, Hantschel O, Georgiou G, Iverson BL.

ACS Chem Biol. 2019 Aug 8. doi: 10.1021/acschembio.9b00283. [Epub ahead of print]

PMID:
31339688
2.

Correction: The Goldilocks Zone of Type I IFNs: Lessons from Human Genetics.

Taft J, Bogunovic D.

J Immunol. 2019 Apr 15;202(8):2511. doi: 10.4049/jimmunol.1900253. Epub 2019 Mar 8. No abstract available.

PMID:
30850478
3.

The Goldilocks Zone of Type I IFNs: Lessons from Human Genetics.

Taft J, Bogunovic D.

J Immunol. 2018 Dec 15;201(12):3479-3485. doi: 10.4049/jimmunol.1800764. Review. Erratum in: J Immunol. 2019 Apr 15;202(8):2511.

PMID:
30530500
4.

Deposition of Porous Sorbents on Fabric Supports.

Johnson BJ, Melde BJ, Moore MH, Taft JR.

J Vis Exp. 2018 Jun 12;(136). doi: 10.3791/57331.

5.

A Neutralizing Antibody Recognizing Primarily N-Linked Glycan Targets the Silent Face of the HIV Envelope.

Zhou T, Zheng A, Baxa U, Chuang GY, Georgiev IS, Kong R, O'Dell S, Shahzad-Ul-Hussan S, Shen CH, Tsybovsky Y, Bailer RT, Gift SK, Louder MK, McKee K, Rawi R, Stevenson CH, Stewart-Jones GBE, Taft JD, Waltari E, Yang Y, Zhang B, Shivatare SS, Shivatare VS, Lee CD, Wu CY; NISC Comparative Sequencing Program, Mullikin JC, Bewley CA, Burton DR, Polonis VR, Shapiro L, Wong CH, Mascola JR, Kwong PD, Wu X.

Immunity. 2018 Mar 20;48(3):500-513.e6. doi: 10.1016/j.immuni.2018.02.013. Epub 2018 Mar 13.

6.

Dioxin Exposure Alters Molecular and Morphological Responses to Thyroid Hormone in Xenopus laevis Cultured Cells and Prometamorphic Tadpoles.

Taft JD, Colonnetta MM, Schafer RE, Plick N, Powell WH.

Toxicol Sci. 2018 Jan 1;161(1):196-206. doi: 10.1093/toxsci/kfx213.

7.

Improving Sorbents for Glycerol Capture in Biodiesel Refinement.

Johnson BJ, Melde BJ, Moore MH, Malanoski AP, Taft JR.

Materials (Basel). 2017 Jun 21;10(6). pii: E682. doi: 10.3390/ma10060682.

8.

Sendai virus, an RNA virus with no risk of genomic integration, delivers CRISPR/Cas9 for efficient gene editing.

Park A, Hong P, Won ST, Thibault PA, Vigant F, Oguntuyo KY, Taft JD, Lee B.

Mol Ther Methods Clin Dev. 2016 Aug 24;3:16057. doi: 10.1038/mtm.2016.57. eCollection 2016.

9.

Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody.

Kong R, Xu K, Zhou T, Acharya P, Lemmin T, Liu K, Ozorowski G, Soto C, Taft JD, Bailer RT, Cale EM, Chen L, Choi CW, Chuang GY, Doria-Rose NA, Druz A, Georgiev IS, Gorman J, Huang J, Joyce MG, Louder MK, Ma X, McKee K, O'Dell S, Pancera M, Yang Y, Blanchard SC, Mothes W, Burton DR, Koff WC, Connors M, Ward AB, Kwong PD, Mascola JR.

Science. 2016 May 13;352(6287):828-33. doi: 10.1126/science.aae0474.

10.

Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G.

Stewart-Jones GB, Soto C, Lemmin T, Chuang GY, Druz A, Kong R, Thomas PV, Wagh K, Zhou T, Behrens AJ, Bylund T, Choi CW, Davison JR, Georgiev IS, Joyce MG, Kwon YD, Pancera M, Taft J, Yang Y, Zhang B, Shivatare SS, Shivatare VS, Lee CC, Wu CY, Bewley CA, Burton DR, Koff WC, Connors M, Crispin M, Baxa U, Korber BT, Wong CH, Mascola JR, Kwong PD.

Cell. 2016 May 5;165(4):813-26. doi: 10.1016/j.cell.2016.04.010. Epub 2016 Apr 21.

11.

Private-Sector Social Franchising to Accelerate Family Planning Access, Choice, and Quality: Results From Marie Stopes International.

Munroe E, Hayes B, Taft J.

Glob Health Sci Pract. 2015 Jun 17;3(2):195-208. doi: 10.9745/GHSP-D-15-00056.

12.

Yeast Endoplasmic Reticulum Sequestration Screening for the Engineering of Proteases from Libraries Expressed in Yeast.

Yi L, Taft JM, Li Q, Gebhard MC, Georgiou G, Iverson BL.

Methods Mol Biol. 2015;1319:81-93. doi: 10.1007/978-1-4939-2748-7_5.

PMID:
26060071
13.

Implementing the Friends and Family Test.

Mcintyre L, Davies K, Fox C, Taft J.

Nurs Times. 2014 Nov 5-11;110(45):12-4.

PMID:
26016093
14.

Improving neutralization potency and breadth by combining broadly reactive HIV-1 antibodies targeting major neutralization epitopes.

Kong R, Louder MK, Wagh K, Bailer RT, deCamp A, Greene K, Gao H, Taft JD, Gazumyan A, Liu C, Nussenzweig MC, Korber B, Montefiori DC, Mascola JR.

J Virol. 2015 Mar;89(5):2659-71. doi: 10.1128/JVI.03136-14. Epub 2014 Dec 17.

15.

Recombinant antibodies to histone post-translational modifications.

Hattori T, Taft JM, Swist KM, Luo H, Witt H, Slattery M, Koide A, Ruthenburg AJ, Krajewski K, Strahl BD, White KP, Farnham PJ, Zhao Y, Koide S.

Nat Methods. 2013 Oct;10(10):992-5. doi: 10.1038/nmeth.2605. Epub 2013 Aug 18.

16.

Engineering of TEV protease variants by yeast ER sequestration screening (YESS) of combinatorial libraries.

Yi L, Gebhard MC, Li Q, Taft JM, Georgiou G, Iverson BL.

Proc Natl Acad Sci U S A. 2013 Apr 30;110(18):7229-34. doi: 10.1073/pnas.1215994110. Epub 2013 Apr 15.

17.

Extraction of Perchlorate Using Porous Organosilicate Materials.

Johnson BJ, Leska IA, Melde BJ, Siefert RL, Malanoski AP, Moore MH, Taft JR, Deschamps JR.

Materials (Basel). 2013 Apr 2;6(4):1403-1419. doi: 10.3390/ma6041403.

18.

Toward in situ monitoring of water contamination by nitroenergetic compounds.

Johnson BJ, Leska IA, Medina A, Dyson NF, Nasir M, Melde BJ, Taft JR, Charles PT.

Sensors (Basel). 2012 Nov 6;12(11):14953-67. doi: 10.3390/s121114953.

19.

Helping to ensure safer transitions in hospitals.

AAPA Quality Care Committee, Taft J.

JAAPA. 2008 Mar;21(3):59-61. No abstract available.

PMID:
18432049
20.

A day in the life of James Taft.

Taft JM.

JAAPA. 2006 Oct;19(10):17-8. No abstract available.

PMID:
17066675
21.

Tolerance of high-dose (3,000 mg/day) coenzyme Q10 in ALS.

Ferrante KL, Shefner J, Zhang H, Betensky R, O'Brien M, Yu H, Fantasia M, Taft J, Beal MF, Traynor B, Newhall K, Donofrio P, Caress J, Ashburn C, Freiberg B, O'Neill C, Paladenech C, Walker T, Pestronk A, Abrams B, Florence J, Renna R, Schierbecker J, Malkus B, Cudkowicz M.

Neurology. 2005 Dec 13;65(11):1834-6.

PMID:
16344537
22.

Distribution of GFAP+ astrocytes in adult and neonatal rat brain.

Taft JR, Vertes RP, Perry GW.

Int J Neurosci. 2005 Sep;115(9):1333-43.

PMID:
16048809
23.

A clinical trial of creatine in ALS.

Shefner JM, Cudkowicz ME, Schoenfeld D, Conrad T, Taft J, Chilton M, Urbinelli L, Qureshi M, Zhang H, Pestronk A, Caress J, Donofrio P, Sorenson E, Bradley W, Lomen-Hoerth C, Pioro E, Rezania K, Ross M, Pascuzzi R, Heiman-Patterson T, Tandan R, Mitsumoto H, Rothstein J, Smith-Palmer T, MacDonald D, Burke D; NEALS Consortium.

Neurology. 2004 Nov 9;63(9):1656-61.

PMID:
15534251
24.
25.
26.

Cairo is working. USA. The Hague Forum.

Taft JV.

Integration. 1999 Summer;(60):34.

PMID:
12322193
27.

The use of non-invasive positive pressure ventilation (NIPPV) in ALS patients. A need for improved determination of intervention timing.

Sivak ED, Shefner JM, Mitsumoto H, Taft JM.

Amyotroph Lateral Scler Other Motor Neuron Disord. 2001 Sep;2(3):139-45.

PMID:
11771770
28.

Management of new-onset atrial fibrillation.

Taft JM, Davis RH Jr, Donnelly RE, Leger MM, Muma RD, Toth SA.

JAAPA. 2001 May;14(5):12, 15. No abstract available.

PMID:
11523335
29.

Reducing the dangers of pediatric pneumococcal disease with a new vaccine.

Toth S, Davis RH Jr, Donnelly RE, Leger MM, Muma RD, Taft JM.

JAAPA. 2001 Feb;14(2):58-9. No abstract available.

PMID:
11523192
30.

Update on adult immunization.

Donnelly RE, Davis RH Jr, Leger MM, Muma RD, Taft JM, Toth SA.

JAAPA. 2001 Jul;14(7):19-20, 34. No abstract available.

PMID:
11517818
31.

The growing presence of complementary and alternative medicine.

Davis RH Jr, Donnelly RE, Girard SS, Muma RD, Taft JM, Toth SA.

JAAPA. 2000 May;13(5):89-90, 93-6, 101 passim. Review. No abstract available.

PMID:
11503416
32.

Physician assistants and the practice of neurology.

Taft JM, Hooker RS.

JAAPA. 2000 Mar;13(3):97-100, 103-4, 106.

PMID:
11503407
33.

Childhood immunization: schedule for 2000.

Toth SA, Davis RH Jr, Donnelly RE, Girard SS, Muma RD, Taft JM.

JAAPA. 2000 Mar;13(3):108-10. No abstract available.

PMID:
11503388
34.

Managing minor closed head injury in children.

Taft JM, Davis RH Jr, Donnelly RE, Girard SS, Muma RD, Toth SA.

JAAPA. 1999 Dec;12(12):37-9. Review. No abstract available.

PMID:
11010081
35.

Revised guidelines for preventing poliomyelitis.

Taft JM.

JAAPA. 1999 Nov;12(11):24, 27. No abstract available.

PMID:
10747642
36.

Physician assistants in neurology practice.

Taft JM, Hooker RS.

Neurology. 1999 Apr 22;52(7):1513. No abstract available.

PMID:
10227650
37.

The prognostic value of thyrotropin receptor antibody measurement in the early stages of treatment of Graves' disease with antithyroid drugs.

Michelangeli V, Poon C, Taft J, Newnham H, Topliss D, Colman P.

Thyroid. 1998 Feb;8(2):119-24.

PMID:
9510119
38.

Microalbuminuria in diabetes.

Jerums G, Cooper M, Gilbert R, O'Brien R, Taft J.

Med J Aust. 1994 Aug 15;161(4):265-8.

PMID:
8047035
39.

Clinical and histological correlations of decline in renal function in diabetic patients with proteinuria.

Taft JL, Nolan CJ, Yeung SP, Hewitson TD, Martin FI.

Diabetes. 1994 Aug;43(8):1046-51.

PMID:
8039599
40.

Microalbuminuria: prognostic and therapeutic implications in diabetes mellitus.

Gilbert RE, Cooper ME, McNally PG, O'Brien RC, Taft J, Jerums G.

Diabet Med. 1994 Aug-Sep;11(7):636-45. Review.

PMID:
7955987
41.

Intrathecal thyrotropin-releasing hormone does not alter the progressive course of ALS: experience with an intrathecal drug delivery system.

Munsat TL, Taft J, Jackson IM, Andres PL, Hollander D, Skerry L, Ordman M, Kasdon D, Finison L.

Neurology. 1992 May;42(5):1049-53.

PMID:
1579228
42.

A clinical-histological study of individuals with diabetes mellitus and proteinuria.

Taft JL, Billson VR, Nankervis A, Kincaid-Smith P, Martin FI.

Diabet Med. 1990 Mar-Apr;7(3):215-21.

PMID:
2139392
43.

TRH and diseases of the motor system.

Munsat TL, Lechan R, Taft JM, Jackson IM, Reichlin S.

Ann N Y Acad Sci. 1989;553:388-98. Review. No abstract available.

PMID:
2497682
44.

Lack of effect of gliclazide on platelet aggregation in insulin-treated and non-insulin-treated diabetes: a two-year controlled study.

Larkins RG, Jerums G, Taft JL, Godfrey H, Smith IL, Martin TJ.

Diabetes Res Clin Pract. 1988 Jan 7;4(2):81-7.

PMID:
3125029
45.

Prolonged intrathecal infusion of thyrotropin releasing hormone in amyotrophic lateral sclerosis.

Munsat TL, Taft J, Kasdon D, Jackson IM.

Ann N Y Acad Sci. 1988;531:187-93. No abstract available.

PMID:
3132882
46.

Pharmacokinetics of intrathecal thyrotropin-releasing hormone.

Munsat TL, Taft J, Jackson IM.

Neurology. 1987 Apr;37(4):597-601.

PMID:
3104819
47.

Intrathecal thyrotropin-releasing hormone in amyotrophic lateral sclerosis.

Munsat TL, Taft J, Kasdon D.

Neurol Clin. 1987 Feb;5(1):159-70. Review.

PMID:
3104751
49.

A role for calmodulin in renal production of 1,25-dihydroxyvitamin D3.

Taft JL, Shaw M, Danks JA, Prince RL, Larkins RG.

Endocrinology. 1986 Sep;119(3):1131-6.

PMID:
3755394
50.

A role for the cytoskeleton in renal vitamin D metabolism.

Taft JL, Larkins RG.

Biochem Biophys Res Commun. 1986 Jan 14;134(1):218-26.

PMID:
3753865

Supplemental Content

Support Center